Bonakdaran Shokoufeh, Shoeibi Nasser
Endocrine Research Center, Mashhad University of Medical Sciences, Ghaem Hospital, Mashhad 91766, Iran.
Retina Research Center, Mashhad University of Medical Sciences, Mashhad 91766, Iran.
Int J Ophthalmol. 2015 Apr 18;8(2):326-31. doi: 10.3980/j.issn.2222-3959.2015.02.20. eCollection 2015.
To determine a relation between vitamin D level, which is an inhibitor of angiogenesis, and diabetic retinopathy and its risk factors.
In a clinic-based cross sectional study two hundred and thirty-five type 2 diabetic patients older than 20y were selected. Patients were classified according to ophthalmologic examination as following: no diabetic retinopathy (NDR) (n=153), non-proliferative diabetic retinopathy (NPDR) (n=64) and proliferative diabetic retinopathy (PDR) (n=18). Study subjects were tested for fasting blood glucose, glycated hemoglobin A1C (HbA1C), lipid profile, microalbuminuria, HsCRP, IGF1, insulin (in patients without history of insulin taking) and 25 hydroxy vitamin D [25 (OH) D] levels. Vitamin D insufficiency was defined according to 25 (OH) D level less than 30 ng/mL. The relationship between diabetic retinopathy and serum 25 (OH) D insufficiency was evaluated.
The prevalence of diabetic retinopathy was 34.8% in our patients. Long duration of diabetes, hypertension, poor glycemic control, diabetic nephropathy, hyperinsulinemia and insulin resistance were risk factors for diabetic retinopathy but 25 (OH) D level was not significant different between NDR, NPDR and PDR groups. Correlation between 25 (OH) D level and other known risk factors of diabetic retinopathy was not significant.
This study did not find any association between diabetic retinopathy and its severity and vitamin D insufficiency. Vitamin D insufficiency is not related to risk factors of diabetic retinopathy.
确定血管生成抑制剂维生素D水平与糖尿病视网膜病变及其危险因素之间的关系。
在一项基于门诊的横断面研究中,选取了235例年龄超过20岁的2型糖尿病患者。根据眼科检查将患者分类如下:无糖尿病视网膜病变(NDR)(n = 153)、非增殖性糖尿病视网膜病变(NPDR)(n = 64)和增殖性糖尿病视网膜病变(PDR)(n = 18)。对研究对象进行空腹血糖、糖化血红蛋白A1C(HbA1C)、血脂谱、微量白蛋白尿、超敏C反应蛋白(HsCRP)、胰岛素样生长因子1(IGF1)、胰岛素(无胰岛素用药史的患者)和25羟维生素D [25(OH)D]水平检测。维生素D不足根据25(OH)D水平低于30 ng/mL定义。评估糖尿病视网膜病变与血清25(OH)D不足之间的关系。
我们的患者中糖尿病视网膜病变的患病率为34.8%。糖尿病病程长、高血压、血糖控制差、糖尿病肾病、高胰岛素血症和胰岛素抵抗是糖尿病视网膜病变的危险因素,但NDR、NPDR和PDR组之间的25(OH)D水平无显著差异。25(OH)D水平与糖尿病视网膜病变的其他已知危险因素之间的相关性不显著。
本研究未发现糖尿病视网膜病变及其严重程度与维生素D不足之间存在任何关联。维生素D不足与糖尿病视网膜病变的危险因素无关。